Northwestern Mutual Wealth Management CO Lantern Pharma Inc. Transaction History
Northwestern Mutual Wealth Management CO
- $147 Billion
- Q3 2025
A detailed history of Northwestern Mutual Wealth Management CO transactions in Lantern Pharma Inc. stock. As of the latest transaction made, Northwestern Mutual Wealth Management CO holds 500 shares of LTRN stock, worth $1,735. This represents 0.0% of its overall portfolio holdings.
Number of Shares
500
Previous 500
-0.0%
Holding current value
$1,735
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding LTRN
# of Institutions
33Shares Held
2.26MCall Options Held
18.4KPut Options Held
0-
Bios Capital Management, LP Fort Worth, TX1.02MShares$3.52 Million4.97% of portfolio
-
Vanguard Group Inc Valley Forge, PA384KShares$1.33 Million0.0% of portfolio
-
Cm Management, LLC225KShares$780,7500.92% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny100KShares$347,3470.0% of portfolio
-
Geode Capital Management, LLC Boston, MA92.1KShares$319,5210.0% of portfolio
About Lantern Pharma Inc.
- Ticker LTRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,830,900
- Market Cap $37.6M
- Description
- Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-30...